These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9233568)

  • 1. Further evidence for the importance of an androgen response element in the factor IX promoter.
    Morgan GE; Rowley G; Green PM; Chisholm M; Giannelli F; Brownlee GG
    Br J Haematol; 1997 Jul; 98(1):79-85. PubMed ID: 9233568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophilia B Leyden: substitution of thymine for guanine at position -21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoter.
    Reijnen MJ; Peerlinck K; Maasdam D; Bertina RM; Reitsma PH
    Blood; 1993 Jul; 82(1):151-8. PubMed ID: 8324220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter.
    Crossley M; Ludwig M; Stowell KM; De Vos P; Olek K; Brownlee GG
    Science; 1992 Jul; 257(5068):377-9. PubMed ID: 1631558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilia B Leyden: the effect of mutations at position +13 on the liver-specific transcription of the factor IX gene.
    Reijnen MJ; Maasdam D; Bertina RM; Reitsma PH
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):341-8. PubMed ID: 8075306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter region.
    Royle G; Van de Water NS; Berry E; Ockelford PA; Browett PJ
    Br J Haematol; 1991 Feb; 77(2):191-4. PubMed ID: 2004020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory mechanism of human factor IX gene: protein binding at the Leyden-specific region.
    Kurachi S; Furukawa M; Salier JP; Wu CT; Wilson EJ; French FS; Kurachi K
    Biochemistry; 1994 Feb; 33(6):1580-91. PubMed ID: 8312279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
    Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
    Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional control of the factor IX gene: analysis of five cis-acting elements and the deleterious effects of naturally occurring hemophilia B Leyden mutations.
    Picketts DJ; Mueller CR; Lillicrap D
    Blood; 1994 Nov; 84(9):2992-3000. PubMed ID: 7949171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B.
    Crossley M; Brownlee GG
    Nature; 1990 May; 345(6274):444-6. PubMed ID: 2342576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype).
    Reitsma PH; Mandalaki T; Kasper CK; Bertina RM; Briët E
    Blood; 1989 Feb; 73(3):743-6. PubMed ID: 2917196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new case of severe hemophilia B Leyden, associated with a G to C mutation at position -6 of the factor IX promoter.
    Nguyen P; Cornillet P; Potron G
    Am J Hematol; 1995 Jul; 49(3):259-60. PubMed ID: 7604825
    [No Abstract]   [Full Text] [Related]  

  • 12. Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden.
    Reijnen MJ; Sladek FM; Bertina RM; Reitsma PH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6300-3. PubMed ID: 1631121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy between transcription factors DBP and C/EBP compensates for a haemophilia B Leyden factor IX mutation.
    Picketts DJ; Lillicrap DP; Mueller CR
    Nat Genet; 1993 Feb; 3(2):175-9. PubMed ID: 8499951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The putative factor IX gene promoter in hemophilia B Leyden.
    Reitsma PH; Bertina RM; Ploos van Amstel JK; Riemens A; Briët E
    Blood; 1988 Sep; 72(3):1074-6. PubMed ID: 3416069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Christmas disease in a Hovawart family resembling human hemophilia B Leyden is caused by a single nucleotide deletion in a highly conserved transcription factor binding site of the
    Brenig B; Steingräber L; Shan S; Xu F; Hirschfeld M; Andag R; Spengeler M; Dietschi E; Mischke R; Leeb T
    Haematologica; 2019 Nov; 104(11):2307-2313. PubMed ID: 30846504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilia B Liverpool: a new British family with mild haemophilia B associated with a -6 G to A mutation in the factor IX promoter.
    Stowell KM; Figueiredo MS; Brownlee GG; Jones P; Bolton-Maggs PH
    Br J Haematol; 1993 Sep; 85(1):188-90. PubMed ID: 8251390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the human factor IX promoter by the orphan receptor superfamily factor, HNF4, ARP1 and COUP/Ear3.
    Naka H; Brownlee GG
    Br J Haematol; 1996 Jan; 92(1):231-40. PubMed ID: 8562402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate hemophilia B Leyden: identification by polymerase chain reaction, sequencing, and oligomer restriction.
    Coyle TE; Spicer T; Michalovic D; Poiesz BJ
    Am J Hematol; 1994 Jul; 46(3):234-40. PubMed ID: 7677806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An A to T transversion at position -5 of the factor IX promoter results in hemophilia B.
    Picketts DJ; D'Souza C; Bridge PJ; Lillicrap D
    Genomics; 1992 Jan; 12(1):161-3. PubMed ID: 1733855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early elevation of factor IX level in japanese brothers with Haemophilia B Leyden who are carrying c. -35 g > a mutations in the promoter region of F9.
    Tamura A; Shinozawa K; Uemura S; Nakamura S; Fujiwara T; Tahara T; Yamamoto N; Saito A; Kozaki A; Kishimoto K; Ishida T; Hasegawa D; Muramatsu T; Amano K; Fukutake K; Kosaka Y
    Haemophilia; 2021 Jul; 27(4):e510-e512. PubMed ID: 33427373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.